Follow
Swarali Joshi
Swarali Joshi
National institute of Pharmaceutical education and research, Ahmedabad
Verified email at niperahm.res.in
Title
Cited by
Cited by
Year
Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt/Erk-NFκB axis in oral cancer
S Joshi, R Pandey, A Kumar, V Gupta, N Arya
Cytokine 166, 156155, 2023
92023
Discovery of fluorinated 2‑Styryl 4 (3H)-quinazolinone as potential therapeutic hit for oral cancer
DP Satpute, U Shirwadkar, AK Tharalla, SD Shinde, GN Vaidya, S Joshi, ...
Bioorganic & Medicinal Chemistry 81, 117193, 2023
22023
Design and synthesis of novel quinazolinone-based pyruvate kinase M2 activators as selective inhibitors of oral cancer cells
B Rathod, S Joshi, S Regu, K Manikanta, H Kumar, S Dubey, ...
Journal of Molecular Structure 1304, 137595, 2024
12024
Modulation of tumour pyruvate kinase M2 and suppression of cancer cell proliferation using natural and synthetic antioxidants
S Kapoor, S Kutre, S Joshi, A Goswami, A Singh, PK Teja, K Jadhav, ...
Journal of Molecular Structure 1305, 137751, 2024
2024
Roadmap for Lung Cancer Treatment: Role of Natural and Synthetic Inhibitors
RG Swarali Joshi, Shaikh Raisa Parveen, Samdisha Dubey, Rutuja Satvase, Anil ...
EC PULMONOLOGY AND RESPIRATORY MEDICINE, 94-106, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–5